Pfizer, BioNTech Report Positive Data From Omicron-adapted COVID-19 Vaccine Candidate Trial
25/6 16:40
(RTTNews) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced positive data from the Phase 2/3 trial evaluating the safety, tolerability, and immunogenicity of Omicron-adapted COVID-19 vaccine candidates against Omicron....